US Patent Issued to POLARIS GROUP on April 22 for "Combination cancer immunotherapies with arginine depletion agents" (California Inventors)

ALEXANDRIA, Va., June 6 -- United States Patent no. 12,281,339, issued on April 22, was assigned to POLARIS GROUP (Grand Cayman, Cayman Islands).

"Combination cancer immunotherapies with arginine depletion agents" was invented by Elena Brin (San Diego) and Wei He (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are arginine depletion agents such as ADI-PEG for use in combination with cancer immunotherapies, for example, immune checkpoint modulators and T-cell adoptive immunotherapies, for treating various cancers. Also provided are related methods, compositions, patient care kits, and cell cultures."

The patent was filed on July 5, 2017, under Application No. 15/641,819.

*For further info...